Jensen, Michael C; Riddell, Stanley R (2015) Designing chimeric antigen receptors to effectively and safely target tumors. Curr Opin Immunol 33:9-15
|
Berger, Carolina; Sommermeyer, Daniel; Hudecek, Michael et al. (2015) Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells. Cancer Immunol Res 3:206-16
|
Jensen, Michael C; Riddell, Stanley R (2014) Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol Rev 257:127-44
|
Berger, Carolina; Berger, Michael; Beard, Brian C et al. (2013) Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques. PLoS One 8:e56268
|
Green, Margaret L; Leisenring, Wendy M; Xie, Hu et al. (2013) CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood 122:1316-24
|
McGoldrick, Suzanne M; Bleakley, Marie E; Guerrero, Abraham et al. (2013) Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo. Blood 121:2796-803
|
Goodridge, Jodie P; Lee, Ni; Burian, Aura et al. (2013) HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol 191:1567-77
|
Riolobos, Laura; Hirata, Roli K; Turtle, Cameron J et al. (2013) HLA engineering of human pluripotent stem cells. Mol Ther 21:1232-41
|
Guerrero, Abraham; Riddell, Stanley R; Storek, Jan et al. (2012) Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation. Biol Blood Marrow Transplant 18:66-75
|
Kim, Sungchul; Lee, Sanghyun; Shin, Jinwook et al. (2011) Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12:984-91
|
Showing the most recent 10 out of 24 publications